Tivity Health Inc (NASDAQ:TVTY) – Research analysts at SunTrust Banks lifted their FY2017 earnings per share estimates for Tivity Health in a report issued on Friday. SunTrust Banks analyst D. Macdonald now expects that the company will earn $1.62 per share for the year, up from their prior forecast of $1.54. SunTrust Banks has a “Buy” rating and a $50.00 price target on the stock. SunTrust Banks also issued estimates for Tivity Health’s Q4 2017 earnings at $0.34 EPS, Q1 2018 earnings at $0.41 EPS, Q2 2018 earnings at $0.44 EPS, Q3 2018 earnings at $0.44 EPS, Q4 2018 earnings at $0.44 EPS, FY2018 earnings at $1.74 EPS, Q1 2019 earnings at $0.48 EPS, Q2 2019 earnings at $0.50 EPS, Q3 2019 earnings at $0.50 EPS and FY2019 earnings at $1.96 EPS.
Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.10. Tivity Health had a return on equity of 30.87% and a net margin of 12.41%. The business had revenue of $137.70 million during the quarter, compared to analysts’ expectations of $137.95 million. The business’s quarterly revenue was up 10.2% on a year-over-year basis.
A number of other analysts also recently commented on TVTY. Barrington Research boosted their price objective on Tivity Health from $35.00 to $44.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded Tivity Health from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Chardan Capital started coverage on Tivity Health in a research note on Tuesday, August 29th. They issued a “neutral” rating and a $40.00 price objective on the stock. ValuEngine raised Tivity Health from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $46.00 price objective on shares of Tivity Health in a research note on Monday, September 25th. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $44.29.
Tivity Health (NASDAQ:TVTY) opened at 45.00 on Monday. The stock has a market cap of $1.77 billion, a PE ratio of 20.27 and a beta of 0.38. Tivity Health has a 12 month low of $19.25 and a 12 month high of $47.90. The stock has a 50 day moving average price of $40.52 and a 200-day moving average price of $37.41.
In other news, insider Mary Flipse sold 14,020 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $37.03, for a total transaction of $519,160.60. Following the sale, the insider now directly owns 61,167 shares of the company’s stock, valued at $2,265,014.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Glenn Hargreaves sold 21,105 shares of the business’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $38.00, for a total value of $801,990.00. Following the sale, the insider now directly owns 59,077 shares in the company, valued at $2,244,926. The disclosure for this sale can be found here. Insiders have sold 74,858 shares of company stock worth $2,847,017 over the last ninety days. 8.42% of the stock is owned by insiders.
Several institutional investors have recently made changes to their positions in TVTY. Flinton Capital Management LLC raised its position in shares of Tivity Health by 63.5% during the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after purchasing an additional 1,360 shares during the period. Riverhead Capital Management LLC raised its position in shares of Tivity Health by 69.7% during the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares during the period. Karp Capital Management Corp acquired a new stake in shares of Tivity Health during the first quarter worth $225,000. UBS Asset Management Americas Inc. acquired a new stake in shares of Tivity Health during the first quarter worth $242,000. Finally, California Public Employees Retirement System acquired a new stake in shares of Tivity Health during the first quarter worth $247,000.
Tivity Health Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
What are top analysts saying about Tivity Health Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Tivity Health Inc and related companies.